BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22034818)

  • 1. Inhibiting tumor-cell growth by novel truncated staphylococcal enterotoxin C2 mutant.
    Hui J; Xiao F; Li H; Cui X; Liu H; Hu F
    Sheng Wu Gong Cheng Xue Bao; 2011 Jun; 27(6):891-9. PubMed ID: 22034818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of the disulphide loop mutant of staphylococcal enterotoxin C2.
    Wang X; Xu M; Cai Y; Yang H; Zhang H; Zhang C
    Appl Microbiol Biotechnol; 2009 Apr; 82(5):861-71. PubMed ID: 19082587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and bioactivity analysis of Staphylococcal enterotoxin M and N.
    Pan YQ; Ding D; Li DX; Chen SQ
    Protein Expr Purif; 2007 Dec; 56(2):286-92. PubMed ID: 17910920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological analysis of the deletion mutants of Staphylococcal enterotoxin C2.
    Wang X; Zhang H; Xu M; Liu C; Zhang C
    Appl Microbiol Biotechnol; 2009 Jul; 83(6):1077-84. PubMed ID: 19296099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
    Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI
    Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of superantigen activity and antitumor response of staphylococcal enterotoxin C2 by site-directed mutagenesis.
    Wang X; Xu M; Zhang H; Liu J; Li X; Zhang C
    Cancer Immunol Immunother; 2009 May; 58(5):677-86. PubMed ID: 18818919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumour response of a double mutant of staphylococcal enterotoxin C2 with the decreased affinity for MHC class II molecule.
    Cheng X; Cao P; Ji X; Lu W; Cai X; Hu C; Wang Z; Zhang S
    Scand J Immunol; 2010 Mar; 71(3):169-75. PubMed ID: 20415782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological characterization of the zinc site coordinating histidine residues of staphylococcal enterotoxin C2.
    Wang X; Zhang H; Xu M; Cai Y; Liu C; Su Z; Zhang C
    Microbiology (Reading); 2009 Mar; 155(Pt 3):680-686. PubMed ID: 19246739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus aureus enterotoxin C2 mutants: biological activity assay in vitro.
    Hui J; Cao Y; Xiao F; Zhang J; Li H; Hu F
    J Ind Microbiol Biotechnol; 2008 Sep; 35(9):975-80. PubMed ID: 18506495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and bioactivity analysis of staphylococcal enterotoxin G and staphylococcal enterotoxin I.
    Chen B; Akash MS; Rehman K; Sun H; Chen S
    Pharm Biol; 2014 Jan; 52(1):8-13. PubMed ID: 23915110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enhanced SEC2 mutants and their superantigen activities].
    Zhang G; Xu M; Sun J; Li H; Yang H; Zhang H; Zhang C
    Sheng Wu Gong Cheng Xue Bao; 2013 Jun; 29(6):803-13. PubMed ID: 24063239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor activity and immunogenicity of a mutated staphylococcal enterotoxin C2.
    Zhang J; Cai YM; Xu MK; Song ZH; Li CY; Wang HR; Dai HH; Zhang ZP; Liu CX
    Pharmazie; 2013 May; 68(5):359-64. PubMed ID: 23802434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and bioactivity analysis of staphylococcal enterotoxin C2].
    Xue Q; Ying YB; Pan YQ; Li DX; Sun HY; Chen SQ
    Yao Xue Xue Bao; 2006 May; 41(5):406-11. PubMed ID: 16848315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of novel chimeric proteins through the truncation of SEC2 and Sak from Staphylococcus aureus.
    Hui J; Yu XJ; Cui XJ; Mu T; Lin JS; Ni P; Li H; You S; Hu FQ
    Biosci Biotechnol Biochem; 2014; 78(9):1514-21. PubMed ID: 25209498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
    Lamphear JG; Stevens KR; Rich RR
    J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro antitumor effects of a staphylococcal enterotoxin A mutant (SEA-H61D).
    Wang HR; Jiang H; Hao HJ; Zheng YL; Jie KG; Gu J; Jiang YQ
    Cancer Invest; 2010 Oct; 28(8):788-96. PubMed ID: 20504220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell proliferation and antitumour activities of a truncated mutant of staphylococcal enterotoxin C2 with decreased cytokine secretion.
    Zhou J; Liu L; Xu M; Zhang H; Zhang Y; Zhang C
    J Med Microbiol; 2013 Mar; 62(Pt 3):451-456. PubMed ID: 23180479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An engineered superantigen SEC2 exhibits promising antitumor activity and low toxicity.
    Xu M; Wang X; Cai Y; Zhang H; Yang H; Liu C; Zhang C
    Cancer Immunol Immunother; 2011 May; 60(5):705-13. PubMed ID: 21331815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with a nontoxic mutant of staphylococcal enterotoxin A, SEAD227A, protects against enterotoxin-induced emesis in house musk shrews.
    Hu DL; Omoe K; Sashinami H; Shinagawa K; Nakane A
    J Infect Dis; 2009 Feb; 199(3):302-10. PubMed ID: 19133806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological properties of staphylococcal enterotoxin-like toxin type R.
    Omoe K; Imanishi K; Hu DL; Kato H; Takahashi-Omoe H; Nakane A; Uchiyama T; Shinagawa K
    Infect Immun; 2004 Jun; 72(6):3664-7. PubMed ID: 15155681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.